Company: Amgen Inc.
Job title: Principal Scientist
Preclinical Evaluation of Therapeutic Combinations to Enhance Efficacy of T Cell Engagers for Solid Tumors 2:45 pm
• T cell engagers (TCEs) have demonstrated promising clinical activity for solid tumors; however, a large gap exists in our understanding of factors governing response or resistance to TCEs. • Using preclinical immunocompetent mouse tumor models, we have elucidated immunotherapy combinations that can synergize with TCEs toRead more
day: Day Two AM